Years of joint industry-academic engineering suggest that highly engineered single agents will not be the most effective treatments for solid tumors; the solution will be combining the right drugs and administering them in the right way.
The post Innovation in Oncology: The Synergy of New and Old Drugs appeared first on MedCity News.
